Catalyst Wire Dossier Catalyst Wire Dossier

Omidenepag isopropyl

omidenepag isopropyl · Santen Pharmaceutical Asia Pte. Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Omidenepag isopropyl, covering 2022-03-15 to 2022-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl [Phase 4]

See pricing